nach oben

Reactions Weekly

Erschienen in:

01.01.2017 | Case report

Rasagiline

Hypersexuality: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

A 74-year-old man developed hypersexuality during treatment with rasagiline [route not stated]. He had a three year history of idiopathic Parkinson's disease, and was receiving rasagiline 1 mg/day. Two years later, he expressed typical symptoms of hypersexuality including obsessive sexual thoughts and desires without any abnormal impulsive behaviour. Rasagiline was withdrawn and his symptoms immediately disappeared. He was receiving levodopa at three months follow-up. …

Simonet C, et al. Hypersexuality induced by rasagiline in monotherapy in Parkinson's disease. Neurological Sciences 37: 1889-1890, No. 11, Nov 2016. Available from: URL: http://doi.org/10.1007/s10072-016-2668-9 -SpainCrossRefPubMed

Titel: Rasagiline
Hypersexuality: case report
Publikationsdatum: 01.01.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-24888-6

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Rasagiline

Hypersexuality: case report

Excerpt

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Ceritinib/crizotinib

FDA: boxed warning removed for varenicline, bupropion

Ofatumumab/rituximab

Antipsychotics

Leflunomide

Golimumab